Loading...
10 Asia Autoimmune Disorders Reports
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AbbVie Inc., Amgen Inc., Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company
Region Covered: Asia
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Sanofi SA, GlaxoSmithKline plc, Pfizer Inc, Bayer AG, Zimmer Biomet
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Sun Pharmaceuticals Industries Ltd., Johnson & Johnson, Concert Pharmaceuticals Inc., Cipla Inc., Daiichi Sankyo
Region Covered: Asia
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Santen Pharmaceutical Co. Ltd, OASIS Medical, Alcon Inc., Bausch Health Companies Inc., AbbVie Inc. (Allergan PLC)
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: GlaxoSmithKline PLC, Parnell Pharmaceuticals Inc., Bausch Health Companies Inc., 3M company, Quest Products Inc.
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AbbVie Inc, Johnson & Johnson, Pfizer Inc., Sanofi S.A., Bristol-Myers Squibb
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Eli Lilly and Company , GlaxoSmithKline, ImmuPharma PLC , Viatris Inc. , Novartis AG
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AbbVie, Amgen, Johnson and Johnson, Eli Lilly and Company, Pfizer Inc.
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Alexion Pharmaceuticals Inc, Mitsubishi Tanabe Pharma, Astellas Pharma, Bausch Health, UCB S.A.
Region Covered: Asia
Study Period: 2019 - 2029
Major Players: Pfizer, F. Hoffmann-La Roche Ltd., Abbott, Thermo Fisher Scientific Inc., Jubilant Pharma Holdings Inc.
Filter Reports
By Countries
